This is the authors' abstract. We don't add key points for this paper.
Background and Objective The delayed‐on phenomenon (DOP) related to levodopa treatment frequently disturbs quality of life in advanced‐stage Parkinson's disease (PD) patients. The objective of this study was to explore the impact of swallowing dysfunction on the development of DOP. Methods Swallowing function was investigated by endoscopic evaluation in 11 PD patients with the DOP and 9 PD patients without the DOP during the on phase. Residual drug in the pharynx after taking the drug in tablet, capsule, and powder forms was also observed. Results Residual drug was seen in the pharynx in six cases (30.0%). Pooling of saliva, delayed swallowing reflex, and residual drug were more frequent in the DOP group than in the group without the DOP ( P < 0.05). The odds ratios for residual drug in the pharynx, pooling of saliva, and delayed swallowing reflex for the DOP were 42.7 (95% confidence interval, 1.89–962.9), 14.0 (95% confidence interval, 1.25–156.6), and 15.8 (95% confidence interval, 1.75–141.4), respectively. Conclusions These results suggest that swallowing dysfunction leading to residual antiparkinsonian drug in the pharynx has substantial impacts on the DOP in PD patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fukae et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: